AQR Capital Management
GOSS icon

AQR Capital Management’s Gossamer Bio GOSS Stock Holding History

AQR Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.33M Buy
10,126,897
+9,007,657
+805% +$14.2M ﹤0.01% 2015
2025
Q4 		$3.47M Buy
1,119,240
+472,625
+73% +$1.35M ﹤0.01% 1791
2025
Q3 		$1.7M Buy
+646,615
New +$1.43M ﹤0.01% 2083
2023
Q1 		– Sell
-14,473
Closed -$31.4K – 2202
2022
Q4 		$31.4K Buy
+14,473
New +$119K ﹤0.01% 2176

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

AQR Capital Management's GOSS Position: Q1 2026 in Review

AQR Capital Management increased its Gossamer Bio (GOSS) stake by 805% in Q1 2026, buying an estimated $14.2M and bringing the position to 10,126,897 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2015.

AQR Capital Management first reported a position in GOSS in Q4 2022 and has held it in 4 quarters since. The position peaked at $3.47M in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • AQR Capital Management held 10,126,897 shares of Gossamer Bio worth $3.33M as of Q1 2026.
  • AQR Capital Management bought 9,007,657 Gossamer Bio shares in Q1 2026, an estimated $14.2M.
  • Gossamer Bio made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2015 holding.
  • AQR Capital Management first reported a position in Gossamer Bio in Q4 2022 and has held it in 4 quarters since.
  • AQR Capital Management's Gossamer Bio position peaked at $3.47M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.